United Kingdom· GB-APID-19357011000001100
Dicycloverine 20mg tablets
A dicycloverine product containing dicycloverine, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Dicycloverine is registered in 3 of 19 countries.
Countries holding a registration under ATC A03AA07 (dicycloverine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Dicycloverine · ATC A03AA07
3 / 19 countries
- Canada
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dicycloverine costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dicycloverine · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dicycloverine
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- A03AA07
- ATC class
- Dicycloverine
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5025903011019
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
389 interactions on record for dicycloverine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dicycloverine · interactions on record
389 records
- 6 severe
- 194 moderate
- 17 minor
- 172 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dicycloverine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDicyclomineNuCare Pharmaceuticals, Inc.
- CanadaJAMP-DICYCLOMINE HCLJAMP PHARMA CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Latvia · Trigan-Sp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c648ed5-cb40-4e31-8300-3cfdbeaa4e8f GET /v1/drugs/9c648ed5-cb40-4e31-8300-3cfdbeaa4e8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19357011000001100",
"desc": "Dicycloverine 20mg tablets (A A H Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "42353211000001108",
"source": "dmd",
"vtm_id": "775568004",
"strength": "20 mg",
"substance": "Dicycloverine",
"ingredient": "Dicycloverine hydrochloride",
"supplier_code": "3144701000001104"
}See everything about dicycloverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.